Hepatobiliary scintigraphy in 2014

Harvey A. Ziessman

Research output: Contribution to journalReview articlepeer-review

26 Scopus citations


Cholescintigraphy with 99mTc-hepatobiliary radiopharmaceuticals has been an important, clinically useful diagnostic imaging study for almost 4 decades. It continues to be in much clinical demand; however, the indications, methodology, and interpretative criteria have evolved over the years. This review will emphasize state-of-the-art methodology and diagnostic criteria for various clinical indications, including acute cholecystitis, chronic acalculous gallbladder disease, high-grade and partial biliary obstruction, and the postcholecystectomy pain syndrome, including sphincter-of-Oddi dysfunction and biliary atresia. The review will also emphasize the use of diagnostic pharmacologic interventions, particularly sincalide.

Original languageEnglish (US)
Pages (from-to)967-975
Number of pages9
JournalJournal of Nuclear Medicine
Issue number6
StatePublished - Jun 1 2014


  • Acute cholecystitis
  • Biliary dyskinesia
  • Cholescintigraphy
  • Chronic acalculous gallbladder disease
  • Chronic cholecystitis
  • Hepatobiliary scintigraphy

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging


Dive into the research topics of 'Hepatobiliary scintigraphy in 2014'. Together they form a unique fingerprint.

Cite this